Stem Cell-Nanoparticle Drug Complex for Stable Tumor Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional nano anticancer drugs face limitations in cancer targeting ability and efficacy due to dissociation under acidic pH and blood conditions, leading to reduced effectiveness and increased side effects.
Innovation Solution
A stem cell-nano anticancer drug complex is developed, where carbon nanotubes or gold nanoparticles loaded with anticancer drugs are bound to stem cells, utilizing a carboxylated surface and EDC linker to enhance targeting through specific antibodies, maximizing drug delivery to cancer cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional nano anticancer drugs are used, then drug delivery to cancer cells is achieved, but the drugs dissociate under acidic pH and blood conditions, reducing effectiveness and increasing side effects
Solution Approach 1:
The patent uses biodegradable polymer intermediaries to connect anticancer drugs to nanoparticle surfaces. These polymer linkers are designed to be stable under physiological conditions (preventing premature dissociation and side effects) but degrade under specific tumor microenvironment conditions (releasing the drug when needed). This intermediary approach resolves the contradiction by providing conditional stability.
Solution Approach 2:
The patent employs pH-sensitive and enzyme-sensitive parameter changes to control drug release. The drug-nanoparticle conjugate maintains stability at physiological pH and releases the drug under acidic tumor conditions or in presence of specific enzymes. This parameter-based control allows the system to differentiate between healthy and tumor tissues, improving reliability while reducing harmful effects on normal cells.
2Duration of action of moving object
If target anticancer drugs are administered over a long period, then cancer treatment effectiveness is maintained, but tolerance is induced
Solution Approach 1:
The patent enables periodic drug delivery through controlled release mechanisms. The nanoparticle-drug conjugate system releases drugs in periodic bursts as the polymer linkers progressively degrade, maintaining therapeutic levels over extended periods without continuous administration. This periodic release pattern helps prevent tolerance induction while sustaining treatment effectiveness.
Solution Approach 2:
The patent achieves continuous therapeutic action through sustained release mechanisms. The biodegradable polymer linkers provide continuous drug release over time as they degrade, eliminating the need for frequent dosing interruptions. This continuous action maintains treatment effectiveness while reducing the tolerance-inducing effects associated with intermittent high-dose administration.
3Adaptability or versatility
If cocktail therapy with multiple anticancer drugs is used, then various target factors are attacked simultaneously, but serious side effects are induced
Solution Approach 1:
The patent merges multiple therapeutic functions into a single nanoparticle platform. Different anticancer drugs can be conjugated to the same nanoparticle surface through the biodegradable polymer linkers, creating a multi-functional therapeutic agent. This merging approach provides the versatility of cocktail therapy (attacking multiple target factors) while concentrating the drugs in a single targeted delivery system, reducing the cumulative side effects of separate administrations.
Solution Approach 2:
The patent applies local quality by delivering multiple drugs to the specific local site of the tumor. The nanoparticle system targets cancer cells directly, and the polymer-linked drugs are released locally at the tumor site rather than systemically. This localized multi-drug delivery achieves comprehensive target coverage while minimizing exposure of healthy tissues to multiple drugs, thereby reducing serious side effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The complex enhances cancer targeting ability and efficacy while minimizing side effects, demonstrating improved drug loading, retention, and therapeutic outcomes.
Implementation Method 1
preparing an EDC linker bound nanoparticle by linking the EDC to the carboxylated nanoparticle
Implementation Method 2
binding an anticancer drug and an antibody, a functional fragment of the antibody or an antibody mimetic that specifically binds to a stem cell surface marker protein to the EDC linker bound nanoparticle covalently
Implementation Method 3
research is mainly conducted related to a method of effectively delivering biological molecules into cells via endocytosis
Data Source
AI summary
Provided are a stem cell-nano anticancer drug complex in which an anticancer drug based on carbon nanotubes (CNT) and gold (Au) nano particles is loaded on the surface of stem cells, which can overcome side effects of conventional stem cells and targeting limitations of nano anticancer drugs and whose anticancer effect is very excellent, the use thereof, and a method for preparing the same.